Differential Regulation of Airway Smooth Muscle Cell Migration by E-Prostanoid Receptor Subtypes
Authors:
- 1 March 2013
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 48 (3) , 322-329
Abstract
Migration of airway smooth muscle (ASM) cells plays an important role in the pathophysiology of airway hyperresponsiveness and remodeling in asthma. It has been reported that prostaglandin (PG)E2 inhibits migration of ASM cells. Although PGE2 regulates cellular functions via binding to distinct prostanoid EP receptors, the role of EP receptor subtypes in mechanisms underlying cell migration has not been fully elucidated. We investigated the role of EP receptors in the inhibitory effects of PGE2 on the migration of human ASM cells. Migration induced by platelet-derived growth factor (PDGF)-BB (10 ng/ml, 6 h) was assessed by a chemotaxis chamber assay. PDGF-BB–induced cell migration was inhibited by PGE2, the specific EP2 agonist ONO-AE1-259–01, the specific EP4 agonist ONO-AE1-329, and cAMP-mobilizing agents. The inhibition of cell migration by PGE2 was significantly reversed by a blockade of EP2 and EP4 receptors using antagonists or transfection with siRNAs. Moreover, PGE2, the EP2 agonist, and the EP4 agonist significantly increased phosphorylation of small heat shock protein 20, one of the protein substrates for protein kinase A (PKA), with depolymerization of actin. In contrast, the EP3 agonist ONO-AE-248 significantly promoted baseline cell migration without affecting PDGF-BB–induced cell migration. In summary, activation of EP2 and EP4 receptors and subsequent activation of the cAMP/PKA pathway are the main mechanisms of inhibition of ASM cell migration by PGE2. HSP20 phosphorylation by PKA is possibly involved in this mechanism. Conversely, EP3 is potent in promoting cell migration. EP receptor subtypes may be novel therapeutic target molecules in airway remodeling and asthma.Keywords
This publication has 55 references indexed in Scilit:
- Novel cAMP signalling paradigms: therapeutic implications for airway diseaseBritish Journal of Pharmacology, 2012
- Slingshot Isoform-Specific Regulation of Cofilin-Mediated Vascular Smooth Muscle Cell Migration and Neointima FormationArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- EP4 receptor as a new target for bronchodilator therapyThorax, 2011
- Anti‐mitogenic effects of β‐agonists and PGE 2 on airway smooth muscle are PKA dependentThe FASEB Journal, 2010
- Ion channel regulation of intracellular calcium and airway smooth muscle functionPulmonary Pharmacology & Therapeutics, 2009
- Prostanoid receptor antagonists: development strategies and therapeutic applicationsBritish Journal of Pharmacology, 2009
- Calcium flickers steer cell migrationNature, 2009
- Endogenous Gs-Coupled Receptors in Smooth Muscle Exhibit Differential Susceptibility to GRK2/3-Mediated DesensitizationBiochemistry, 2008
- Small heat shock proteins in smooth musclePharmacology & Therapeutics, 2008
- The small heat shock-related protein, HSP20, is a cAMP-dependent protein kinase substrate that is involved in airway smooth muscle relaxationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008